Live Event

GAIN (NSCLC) Regional Summits

EnGAging an Interdisciplinary Team for NSCLC Diagnosis, Personalized Assessment, and Treatment

Nationwide

GAIN Supporters

DESCRIPTION

Through case-based discussions and interactive simulations, these interdisciplinary summits will seek to address specific unmet needs and clinical gaps in the care of patients with known or suspected Non-small Cell Lung Cancer (NSCLC). The goal is to improve the knowledge, competence, and performance of a team of interdisciplinary specialists who are currently responsible for appropriate staging, mediastinal assessment, tissue acquisition, and biomarker analysis in patients with NSCLC.

Participation in the Summit will grant you access to MOC Part II and IV activities being developed by the American College of Chest Physicians and the American Society for Clinical Pathology.

SUMMIT SCHEDULE

Friday, April 6, 2012
Duke University Medical Center
Durham, North Carolina
Register >>

Saturday, April 21, 2012
Mayo Clinic
Rochester, Minnesota

Friday, May 11, 2012
Henry Ford Medical center
Detroit, Michigan

Friday, May 25, 2012
Johns Hopkins Medical Center
Baltimore, Maryland

Friday, June 1, 2012
Cleveland Clinic
Cleveland, Ohio

Saturday, June 23, 2012
University of Texas
MD Anderson Cancer Center
Houston, Texas

Coming Soon!
Caritas St. Elizabeth Medical Center
Boston, Massachusetts

Coming Soon!
University of California, Irvine
Irvine, California

Coming Soon!
Kaiser Permanente
Portland, Oregon

TARGET AUDIENCE

Pulmonologists, Pathologists, Medical Oncologists, Thoracic Surgeons, and Physician Assistants and Nurse Practitioners supporting these clinical practices.

OBJECTIVES

Describe the continuing emergence of tumor biomarkers and targeted therapy in the personalized care of patients with NSCLC

Demonstrate the knowledge and skills required to obtain an adequate tissue sample for NSCLC diagnosis and classification

Identify the current biomarkers utilized to categorize molecular and histologic features of NSCLC and their relevant applications for diagnosis, monitoring, and personalized care

SUMMIT CHAIR

Momen M. Wahidi, MD, MBA
Director, Interventional Pulmonology
Director, Flexible Bronchoscopy
Associate Clinical Chief
Duke University Medical Center

Associate Professor of Medicine
Department of Medicine
Duke University School of Medicine
Durham, North Carolina

SUMMIT STEERING COMMITTEE

Jeffrey Crawford, MD
Chief, Department of Medicine
Division of Medical Oncology and Transplantation
Duke University Medical Center
Associate Director, Clinical Research
Duke Comprehensive Cancer Center
Durham, North Carolina

Eric S. Edell, MD, FCCP
Professor of Medicine
Mayo Clinic
Rochester, Minnesota

Neda Kalhor, MD
Assistant Professor of Pathology
The University of Texas MD Anderson Cancer Center
Houston, Texas

Nicholas J. Pastis Jr, MD, FCCP
Assistant Professor of Pulmonary & Critical Care Medicine
Associate Fellowship Director
Medical University of South Carolina
Charleston, South Carolina

Michael J. Simoff, MD, FCCP
Associate Professor of Medicine
Wayne State University School of Medicine
Director, Bronchoscopy & Interventional Pulmonology
Henry Ford Hospital
Detroit, Michigan

Chad H. Stone, MD
Assistant Clinical Professor of Pathology
Wayne State University School of Medicine
Cytopathology Fellowship Program Director
Henry Ford Hospital
Detroit, Michigan

Accreditation Statement

The American College of Chest Physicians (ACCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The ACCP designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credits™. Individuals should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement

The ACCP remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of the ACCP to eliminate all situations of potential conflict of interest but rather to enable those who are working with the ACCP to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the educational activity course director/chair, the Education Committee, or the Conflict of Interest Review Committee to ensure that such situations are properly evaluated and, if necessary, resolved. The ACCP educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all ACCP CME activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available on-site during all educational activities.